Xeroderma pigmentosum complementation group B
General Information (adopted from Orphanet):
Synonyms, Signs: |
XPB/CS, INCLUDED XP, GROUP B XPBC XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME, INCLUDED XPB |
Number of Symptoms | 32 |
OrphanetNr: | 276252 |
OMIM Id: |
610651
|
ICD-10: |
Q82.1 |
UMLs: |
|
MeSH: |
|
MedDRA: |
|
Snomed: |
|
Prevalence, inheritance and age of onset:
Prevalence: | No data available. |
Inheritance: |
Autosomal recessive [Orphanet] |
Age of onset: |
All ages [Orphanet] |
Disease classification (adopted from Orphanet):
Parent Diseases: |
Autosomal recessive cerebellar ataxia due to a DNA repair defect
-Rare eye disease -Rare genetic disease -Rare neurologic disease Xeroderma pigmentosum -Rare developmental defect during embryogenesis -Rare genetic disease -Rare oncologic disease -Rare skin disease Xeroderma pigmentosum/Cockayne syndrome complex -Rare developmental defect during embryogenesis -Rare eye disease -Rare genetic disease -Rare neurologic disease -Rare oncologic disease -Rare otorhinolaryngologic disease -Rare skin disease |
Symptom Information:
|
(HPO:0000135) | Hypogonadism | 89 / 7739 | ||||
|
(HPO:0000252) | Microcephaly | 832 / 7739 | ||||
|
(HPO:0000568) | Microphthalmia | 183 / 7739 | ||||
|
(HPO:0000580) | Pigmentary retinopathy | 49 / 7739 | ||||
|
(HPO:0000518) | Cataract | 454 / 7739 | ||||
|
(HPO:0000648) | Optic atrophy | 238 / 7739 | ||||
|
(HPO:0000407) | Sensorineural hearing impairment | 524 / 7739 | ||||
|
(HPO:0001251) | Ataxia | 413 / 7739 | ||||
|
(HPO:0001347) | Hyperreflexia | 363 / 7739 | ||||
|
(HPO:0001249) | Intellectual disability | 1089 / 7739 | ||||
|
(HPO:0000762) | Decreased nerve conduction velocity | 36 / 7739 | ||||
|
(HPO:0002135) | Basal ganglia calcification | 37 / 7739 | ||||
|
(HPO:0004322) | Short stature | 1232 / 7739 | ||||
|
(HPO:0002671) | Basal cell carcinoma | 18 / 7739 | ||||
|
(HPO:0012056) | Cutaneous melanoma | 10 / 7739 | ||||
|
(HPO:0001480) | Freckling | 13 / 7739 | ||||
|
(HPO:0004334) | Dermal atrophy | 34 / 7739 | ||||
|
(HPO:0001000) | Abnormality of skin pigmentation | 105 / 7739 | ||||
|
(HPO:0006739) | Squamous cell carcinoma of the skin | 6 / 7739 | ||||
|
(HPO:0000992) | Cutaneous photosensitivity | 75 / 7739 | ||||
|
(HPO:0002860) | Squamous cell carcinoma | 18 / 7739 | ||||
|
(HPO:0005328) | Progeroid facial appearance | 13 / 7739 | ||||
|
(HPO:0003224) | Increased cellular sensitivity to UV light | 8 / 7739 | ||||
|
(HPO:0002861) | Melanoma | 18 / 7739 | ||||
|
(OMIM) | Decreased DNA excision repair | 1 / 7739 | ||||
|
(HPO:0001272) | Cerebellar atrophy | 197 / 7739 | ||||
|
(HPO:0002119) | Ventriculomegaly | 253 / 7739 | ||||
|
(HPO:0012447) | Abnormal myelination | 7 / 7739 | ||||
|
(OMIM) | Increased risk of malignancy | 3 / 7739 | ||||
|
(HPO:0000007) | Autosomal recessive inheritance | 2538 / 7739 | ||||
|
(HPO:0011400) | Abnormal CNS myelination | 10 / 7739 | ||||
|
(OMIM) | Cachectic appearance | 1 / 7739 |
Associated genes:
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Description: (OMIM) |
For a general discussion of xeroderma pigmentosum, see XPA (278700), and of Cockayne syndrome, see CSA (216400). Cleaver (1990) provided a review of the causes of xeroderma pigmentosum. |
Clinical Description OMIM |
Lehmann (1982) performed cell fusion studies on cultured cells from 11 patients with Cockayne syndrome. The 11 cell lines were assigned to 3 complementation groups: 2 to group A, 8 to group B, and 1 to group C. ... |
Genotype-Phenotype Correlations OMIM |
Oh et al. (2006) observed a more severe XPB/Cockayne syndrome phenotype in patients with nonsense mutations in the ERCC3 gene on both alleles compared to those with a partially active missense mutation in the ERCC3 gene on at ... |
Molecular genetics OMIM |
In a patient with XPB/Cockayne syndrome reported by Robbins et al. (1974), Weeda et al. (1990) identified a heterozygous mutation in the ERCC3 gene (133510.0001). Oh et al. (2006) identified a second pathogenic ERCC3 mutation (133510.0005) in this ... |